Cindy Jacobs
2010
In 2010, Cindy Jacobs earned a total compensation of $712.3K as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,500 |
|---|---|
| Option Awards | $226,800 |
| Salary | $369,000 |
| Total | $712,300 |
Jacobs received $369K in salary, accounting for 52% of the total pay in 2010.
Jacobs also received $116.5K in non-equity incentive plan and $226.8K in option awards.
Rankings
In 2010, Cindy Jacobs' compensation ranked 6,497th out of 10,439 executives tracked by ExecPay. In other words, Jacobs earned more than 37.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,497 out of 10,439 | 38th |
Division Manufacturing | 2,358 out of 3,838 | 39th |
Major group Chemicals And Allied Products | 532 out of 921 | 42nd |
Industry group Drugs | 340 out of 680 | 50th |
Industry In Vitro and In Vivo Diagnostic Substances | 19 out of 51 | 63rd |
Source: SEC filing on April 21, 2011.
Jacobs' colleagues
We found three more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2010.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019